Daniela De Zio
12PUBLICATIONS
44CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (12)
Sort by Publication Date:
|Feb 24, 2025
Thiopurine therapy enhances immune checkpoint inhibitor efficacy in low-mutational burden melanoma: A promising anticancer approach.Loulieta Nazerai, Christina Tsiavou, Lina Vardouli
|Jun 13, 2024
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma.Luca Di Leo, Chiara Pagliuca, Ali Kishk
|Jan 27, 2024
An analysis pipeline for understanding 6-thioguanine effects on a mouse tumour genome.Patricio Yankilevich, Loulieta Nazerai, Shona Caroline Willis
|Jul 26, 2023
Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma.Tamara Bintener, Maria Pires Pacheco, Demetra Philippidou
|Mar 03, 2023
Ambra1 modulates the tumor immune microenvironment and response to PD-1 blockade in melanoma.Alex Frias, Luca Di Leo, Asier Antoranz
|Dec 23, 2022
New Insights into the Phenotype Switching of Melanoma.Chiara Pagliuca, Luca Di Leo, Daniela De Zio
Pageof 2
Frequent Collaborators
7 joint publications
Luca Di Leo
3 joint publications
Loulieta Nazerai
3 joint publications
Salvatore Rizza
3 joint publications
Francesco Cecconi
3 joint publications
Giuseppe Filomeni
2 joint publications
Christina Tsiavou
2 joint publications
Chiara Pagliuca
2 joint publications
Thomas Sauter
2 joint publications
Matteo Bordi
2 joint publications
Rosalie C Sears
